This agreement authorizes Siemens Healthcare to share the basic intellectual property of Prowess’s patented Direct Aperture Optimization (DAO) planning software, allowing Siemens to incorporate Prowess’s software into the treatment planning tools for its linear accelerators. This will help users to dramatically reduce the number of segments, monitor units, and overall treatment times.
John Nguyen, CEO of Prowess, said: “Working closely with Siemens, we are developing a joint solution that combines Siemens’ innovative oncology therapy solutions with our market-leading treatment planning system. We look forward to realizing the full potential of this partnership and continuing to drive innovation in the oncology field.”